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Amelogenesis imperfecta (AI) describes a broad group of clinically and genetically heterogeneous inherited
defects of dental enamel bio-mineralization. Despite identiﬁcation of a number of genetic mutations under-
lying AI, the precise causal mechanisms have yet to be determined. Using a multi-disciplinary approach,
we describe here a mis-sense mutation in the mouse Amelx gene resulting in a Y ! H substitution in the
tri-tyrosyl domain of the enamel extracellular matrix protein amelogenin. The enamel in affected animals phe-
nocopies human X-linked AI where similar mutations have been reported. Animals affected by the mutation
have severe defects of enamel bio-mineralization associated with absence of full-length amelogenin protein
in the developing enamel matrix, loss of ameloblast phenotype, increased ameloblast apoptosis and for-
mation of multi-cellular masses. We present evidence to demonstrate that affected ameloblasts express
but fail to secrete full-length amelogenin leading to engorgement of the endoplasmic reticulum/Golgi appar-
atus. Immunohistochemical analysis revealed accumulations of both amelogenin and ameloblastin in
affected cells. Co-transfection of Ambn and mutant Amelx in a eukaryotic cell line also revealed intracellular
abnormalities and increased cytotoxicity compared with cells singly transfected with wild-type Amelx, mutant
Amelx or Ambn or co-transfected with both wild-type Amelx and Ambn. We hypothesize that intracellular
protein–protein interactions mediated via the amelogenin tri-tyrosyl motif are a key mechanistic factor under-
pinning the molecular pathogenesis in this example of AI. This study therefore successfully links phenotype
with underlying genetic lesion in a relevant murine model for human AI.
INTRODUCTION
Amelogenesis imperfecta (AI) is a common group of inherited
defects of dental enamel formation that exhibit marked genetic
and clinical heterogeneity with at least 14 different sub-types
being recognized on the basis of their clinical appearance and
mode of inheritance (1–3). Affected individuals show either
hypoplastic (thin but seemingly correctly mineralized) or
hypomineralized enamel but an overlap of these characteristics
is seen in many cases (2). Autosomal dominant, autosomal
recessive and X-linked forms of AI are recognized. To date,
mutations in the genes encoding amelogenin (AMELX), enam-
elin (ENAM), enamelysin (MMP20), kallikrein 4 (KLK4) and
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syndromic forms of AI (4–6). Despite these advances, the
underlying molecular pathogenesis of the various forms of
AI remains poorly characterized.
Dental enamel isa highlymineralizedtissue with 85% of its
volume occupied by unusually large hydroxyapatite crystals that
areorganizedintoprisms(7).Enamelisuniqueamongtheminer-
alized tissues as it is produced by ectodermally derived amelo-
blasts which pass through a series of discrete differentiation
states that correlate with the various stages of enamel formation
(5). During the pre-secretory stage, ameloblasts are separated
from the adjacent neural crest cell-derived odontoblasts by a
basementmembranewhich issubsequently removed as the ame-
loblasts enter their secretory phase. During this latter stage, the
ameloblasts secrete an eosinophilic, enamel extracellular
matrix of which greater than 90% is composed of amelogenin,
the remainder comprising non-amelogenin proteins including
ameloblastin, enamelin and tuftelin, together with enzymes,
including the proteases enamelysin and kallikrein-4 (7). Bio-
mineralizationof theenamel matrixbegins as itisbeing secreted
and there is no non-mineralized ‘pre-enamel’ equivalent to that
seen in other mineralized tissues of the skeleton such as bone
or dentine. During the secretory phase, extracellular matrix pro-
teins are enzymically processed such that nascent molecules
areconvertedtosmallerfragmentsthatformthegreaterthickness
ofthematrix(7).Astheameloblastsentertheirmaturationphase,
the organic matrix is degraded completely to allow secondary
growth of the hydroxyapatite crystals which ultimately occlude
the spaces previously occupied by the enamel extracellular
matrix proteins. Ultimately, the ameloblasts atrophy and the cel-
lular layer is lost entirely from the mature erupted tissue (7).
One of the difﬁculties in elucidating the underlying molecu-
lar mechanisms associated with AI in humans is the near-
impossibility of obtaining viable, developing (pre-eruptive)
teeth. In contrast, the incisor teeth of adult rodents form and
erupt continuously throughout life and offer access to all
stages of enamel development in a single tooth. The mouse
is therefore an excellent model organism to investigate the
fundamental events driving dental development and for study-
ing the molecular pathogenesis of AI. In this context, gene
targeting experiments have conﬁrmed a central role for amelo-
genin, enamelysin and ameloblastin in enamel formation.
Although ameloblastin may act as a cell adhesion molecule
that is essential for maintaining the differentiation state of
the ameloblasts (8), both amelogenin and enamelysin are
indispensable for the generation of full-thickness enamel of
appropriate crystal structure (9–11). Similarly, analyses of
N-ethyl-N-nitrosourea (ENU)-induced dominantly inherited
mouse mutations have demonstrated that enamelin is required
for the initiation of mineral crystal formation during the early
stages of enamel formation and the generation of full-
thickness enamel (12,13). These studies also reported
animals (mouse mutant M100888) with an X-linked enamel
phenotype immediately suggesting mutations in the amelo-
genin gene (Amelx) as this is the only enamel matrix protein
currently identiﬁed on the X-chromosome. Previously reported
human AMELX mutations include those resulting in a total loss
of secreted protein (e.g. nonsense mutation in the signal
peptide); mutations causing loss of the amelogenin C-terminal,
and mutations affecting the amelogenin N-terminal region that
includes a lectin-like, tri-tyrosyl domain reported to bind to
N-acetyl-D-glucosamine (14).
The amelogenin tri-tyrosyl domain is deﬁned by the
sequence PYPSYGYEPMGGW (15; corresponding to P63 !
W75 in murine amelogenin) and is highly conserved across
the species. A P ! T mutation in the same amelogenin
domain (underlined above), results in hypomaturation AI in
humans (16). In vitro experiments indicated that this mutation
not only inhibited normal amelogenin proteolysis (17) but also
abrogated lectin-like binding by the tri-tyroysl domain (15).
The three tyrosine residues are essential for the lectin-like
properties of the amelogenin tri-tyrosyl domain (15). The tri-
tyrosyl domain also binds the N-acetyl-D-glucosamine
mimicking domain in the N-terminal region of cytokeratin
14 (18) and N-acetyl-D-glucosamine residues on cytokeratin
5 (19). It has therefore been proposed that these cytokeratins
may play a role in amelogenin cell trafﬁcking and secretion.
In the current study, we have identiﬁed a novel
ENU-induced Amelx mutation in M100888 mice which
results in a marked dental phenotype and corresponds to
similar reported mutations in human AI. Furthermore, we
have utilized the continuously erupting incisor teeth of
affected animals to identify an apparent impairment of the
normal extracellular matrix secretory pathway and so present
evidence of a possible underlying mechanism resulting in AI.
RESULTS
Gross morphological analysis of M100888 mutant mice
The mousemutantM100888was identiﬁed duringalarge-scale
screen for dominant abnormal phenotypes of the incisor surface
amonganimalsgeneratedfrominter-crossingmalemicetreated
with ENU and wild-type (WT) female mice (12). Gross mor-
phological analysis of the dentition of affected mice revealed
that the upper and lower incisors were shortened and uneven
and presented a chalky white, opaque appearance with rough-
ened/pitted surfaces. In contrast, WT incisors were smooth
and opalescent (Fig. 1A–F). Examination of the lower jaw
after soft tissue removal indicated that the inferior border of
the mandible of affected male mice was enlarged, eroded and
discoloured compared with their unaffected counterparts. Sub-
sequent removal of the cortical plate further indicated that the
enlarged region of the mandible contained a mass of predomi-
nantly soft tissue (Fig. 1G and H). Dissection of the lower
incisor teeth indicated that the mineralizing enamel distal to
the white opaque zone (where enamel extracellular matrix
removal would normally have occurred) was irregular and dis-
colouredwithridgesperpendiculartothelongaxisoftheincisor
(Fig. 1I and J). Similarly, although the surfaces of the molar
teeth of WT mice were smooth and opalescent, those of the
affected animals were opaque and roughened with abrasion of
the cusps (Fig. 1K and L).
Mutation analysis in M100888 mutant mice
As the mutation underlying the phenotype observed in M100888
mutantmicehadbeenmappedtotheXchromosome(http://www.
gsc.riken.jp/Mouse/), direct sequencing of all the coding exons
and the associated splice junctions of the Amelx gene was
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affected mice was a T to C transition at nucleotide 249 of
the Amelx coding sequence which resulted in the mis-sense
mutation Y64H based on the ENSEMBL sequence
ENSMUST00000112119/P63277-4 (Fig. 2). This mutation
affects the ﬁrst tyrosine residue (Y64) within the conserved tri-
tyrosyl motif (PYPSYGYEPMGGW) of amelogenin which is
positioned towards the C-terminus of the tyrosine-rich amelo-
genin peptide (TRAP) domain. Although this mutation was
present in all affected male (n ¼ 72) and female (n ¼ 54) mice
analysed, it was not detected in their WT littermates (n ¼ 160)
nor in a panel of eight inbred mouse strains. Affected males and
affected female mice that were homozygous for the mutation
were more severely affected than heterozygous females.
Enamel thickness, mineral density and ultrastructural
appearance in M100888 mutant mice
Enamel thickness was signiﬁcantly reduced in Amelx
X/Y64H
heterozygous females compared with their WT littermates
(Fig. 3A). Measurement of enamel thickness for affected
males was impossible to carry out in a meaningful way as
large areas of enamel were missing entirely from the teeth.
Quantitative microradiography of transverse sections through
WT and affected teeth demonstrated a signiﬁcantly reduced
enamel mineral content in Amelx
X/Y64H females (Fig. 3–F;
P , 0.001). Enamel mineral density in affected males was
not signiﬁcantly different to that of WT animals but this
ﬁnding only related to the small amount of enamel that was
Figure 1. Morphology of the dentition of Amelx mutant mice. In wild-type (WT) maxillary (A) and mandibular (B) incisor teeth, the enamel appeared smooth,
opalescent and orange/brown in colour. (C and D) In heterozygous female (Amelx
X/Y64H) mutant mice, the incisor teeth showed patchy regions of roughened,
chalky white enamel. (E and F) In hemizygous male (Amelx
Y/Y64H) mutant mice, the entire enamel surface of the incisor teeth was roughened, opaque and chalky
white. Frequently, the incisor teeth of affected mice were shortened with irregular incisal edges (C–F). (G) The inferior border of the WT mandible appeared
smooth and unremarkable; (H) in contrast, that of Amelx
Y/Y64H mutant mice was enlarged, eroded and discoloured containing a large mass of soft tissue (arrow).
(I) The surface of dissected WT mandibular incisors was smooth with progressive maturation from white, incompletely mineralized enamel at the apex of the
tooth to increasingly pigmented, fully mineralized enamel towards the incisal tip. (J) The surface of mandibular incisors dissected from Amelx
Y/Y64H mice, at the
point where enamel maturation would normally occur, was irregular and discoloured (arrow) with ridges running along the long axis of the tooth. (K) The molar
teeth of WT mice were smooth and opalescent whereas (L) those of Amelx
Y/Y64H mice were opaque and roughened (arrows) with abrasion of the cusps (asterisk).
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ences in mineral levels in the dentine of the teeth of affected
animals compared with WT tissue (Fig. 3B).
The tissue architecture and ultrastructural appearance of
mature incisor enamel in mice carrying the Y64H mutation
were compared with those of WT animals using scanning elec-
tron microscopy (Fig. 3G–J). WTenamelexhibitedtheherring
bone pattern of decussating prisms characteristic of rodent
enamel (Fig. 3G). Although the enamel in Amelx
X/Y64H mice
also showed prismatic structure, this was less highly ordered
than that of WT tissue, with greater inter-prismatic spacing
(Fig. 3H). Enamel from Amelx
Y/Y64H mice could only be
imaged where remnants of the tissue remained. Scanning elec-
tron microscopy revealed severely dysplastic non-prismatic
‘enamel’ with a smooth glass-like appearance and no evidence
of clear prismatic structure (Fig. 3I and J).
Histological appearance of the enamel organ and
developing enamel in M100888 mutant mice
To characterize further the dental phenotype of mice affected
by the Y64H mutation, we performed histological analysis
of mandibular incisors and enamel organs from 2- to 3-month
old WT, affected male (Amel
Y/Y64H), heterozygous female
(Amelx
X/Y64H) and homozygous female (Amelx
Y64H/Y64H)
mice (Fig. 4). In WT lower incisors, the normal cellular com-
ponents of the enamel organ were clearly evident. Towards the
apex of the developing incisor, an epithelial sheet was
observed which differentiated longitudinally towards the
incisal tip to form the tall ameloblasts with distinctive
Tomes’ processes that characterize the secretory stage of ame-
logenesis (20,21). The eosinophilic, enamel extracellular
matrix was also clearly visible (Fig. 4B). Following the
secretory stage, the ameloblasts decreased in height and
increased in width as they progressed through the transi-
tional/early maturation stage of amelogenesis during which
maximum enzyme-mediated matrix degradation occurs
(Fig. 4C). Further towards the incisal tip, this specialized epi-
thelium entered the true maturation phase where the amelo-
blasts shortened further and lost their Tomes’ process and
secretory characteristics (Fig. 4D). Following maturation, the
ameloblasts became cuboidal as they entered the post-
maturation phase (Fig. 4E). These cells progressed forwards
until they reached the gingival margin where the tooth




appeared to differentiate normally, acquiring typical secretory
characteristics and initially elaborating an eosinophilic, extra-
cellular matrix; however, soon after commencement of enamel
matrix production the ameloblasts appeared to lose contact
with their sub-adjacent matrix and their cytoplasm became
atypically eosinophilic (Fig. 4F). At this point, a matrix-free
space was observed between the newly formed enamel and
the ameloblasts. The departure from the phenotypic norm
became more pronounced as amelogenesis proceeded. In
what would normally be regarded as the transition and matu-
ration zones, the cells became highly disorganized with the
ameloblasts losing their characteristic columnar morphology
and forming a multi-cellular mass coincident with that
observed macroscopically associated with erosion of the
inferior border of the mandible (Fig. 4G and H). Surprisingly,
in the post-maturation zone, the ameloblasts regained a sem-
blance of their normal cuboidal morphology (Fig. 4I). Hetero-
zygous Amelx
X/Y64H mice exhibited a milder phenotype
with occasional small ‘blister-like’ structures of variable size
apparent from the late secretory stage onwards (Fig. 4J–M).
Figure 2. Identiﬁcation of the Amelx Y64H mutation. Partial sequence chromatograms of Amelx depicting the WT sequence, and the T ! C transition (asterisks)
thatleads to the Y64H mutationin amelogenin in heterozygous female (Amelx
X/Y64H), hemizygous male (Amelx
Y/Y64H) and homozygousfemale (Amelx
Y64C/Y64H)
mutant mice.
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present with areas appearing less eosinophilic than the original
enamel matrix (Fig. 4J–M). Analysis of molar teeth derived
from mutant mice at post-natal day 7 and their WT littermates
revealed a similar histological appearance for Amelx
Y/Y64H
molars to that noted for the incisor teeth with eosinophilic
ameloblasts that had lost their characteristic morphology and
were detached from the enamel matrix forming multi-cellular
masses (Supplementary Material, Fig. S1).
Immunoﬂuorescence analysis of the enamel organ
and developing enamel in M100888 mutant mice
To determine the effects of the Amelx Y64H mutation on the
distribution of the major enamel extracellular proteins, we per-
formed immunoﬂuorescence studies using antibodies raised
against amelogenin and ameloblastin, which represent
.95% of all developing enamel matrix proteins (Fig. 5 and
Supplementary Material, Fig. S2).
Amelogenin distribution. In the secretory zone of WT incisors,
strong amelogenin immunolabelling of the enamel extracellu-
lar matrix was detected as closely packed parallel lines
corresponding to the prismatic pattern characteristic of the
mature tissue. Staining was particularly strong at the junction
between the enamel and dentine (Fig. 5A). In the transition
zone, where matrix degradation occurs, this staining pattern
was largely lost (Fig. 5B), whereas in the maturation and post-
maturation zones, amelogenin staining of the enamel was lost
entirely (Fig. 5C and D). In contrast, although strong amelo-
genin immunolabelling was detected in the secretory enamel
of Amelx
Y/Y64H and Amelx
Y64H/Y64H mice, no obvious staining
pattern was present other than within a limited region in the
vicinity of the Tomes’ processes of the ameloblasts
(Fig. 5E). Where the ameloblasts were severely disorganized,
strong amelogenin staining was observed both within the
enamel matrix and within the multi-cellular masses (Fig. 5F
and G). Surprisingly, extracellular amelogenin staining per-
sisted into the post-maturation enamel of the incisors of
Amelx
Y/Y64H and Amelx
Y64H/Y64H mice; no organic matrix
was detectable in the corresponding tissue of WT mice
(Fig. 5H). Amelogenin staining of the enamel matrix in the
secretory zone of Amelx
X/Y64H incisors showed a similar,
albeit less well-deﬁned, pattern to that observed in WT
mice; however, amelogenin immunostaining with no obvious
structural organization was also detected in the blister-like
Figure 3. Enamel phenotype of Amelx mutant mice. (A) Enamel thickness in heterozygous female (Amelx
X/Y64H) mutant mice was signiﬁcantly reduced com-
pared with WT (P , 0.05). Enamel thickness in hemizygous males could not be reliably measured due to large areas of enamel being missing from the teeth and
thus no data are presented. (B) Enamel mineral density in Amelx
X/Y64H females was also signiﬁcantly reduced compared with WT littermates (P , 0.001).
Mineral density in hemizygous males was, however, not signiﬁcantly different from WT. There were no signiﬁcant differences in mineral levels in the
dentine of the teeth of affected animals compared with WT tissue. (C–F) Representative transverse sections of mature enamel prepared for quantitative micro-
radiography clearly show qualitative differences in enamel from WT (C), heterozygous females (Amelx
X/Y64H) (D) and hemizygous males (Amelx
Y/Y64H) (E, F).
Scale bars ¼ 100 mm. (G–J) Scanning electron micrographs of WT enamel (G) exhibited decussating prism architecture characteristic of rodent enamel. Enamel
in Amelx
X/Y64H females also showed decussating prisms (H) but they were less highly ordered and possessed a more open structure compared with WT. Enamel
from Amelx
Y/Y64H affected males could only be imaged where remnants of the tissue were present and revealed severely dysplastic non-prismatic ‘enamel’ with a
smooth glass-like appearance (I, J). Scale bars ¼ 20 mm.
1234 Human Molecular Genetics, 2010, Vol. 19, No. 7structures present in transition and maturation zones (Sup-
plementary Material, Fig. S2).
Ameloblastin distribution. In WT mice, ameloblastin immu-
nostaining was observed within secretory ameloblasts, predo-
minantly localizing within the supra-nuclear region. Less
intense ameloblastin immunostaining was also present
towards the apical region (Fig. 5I). Newly formed enamel
matrix, close to the Tomes’ processes of the ameloblasts
also stained intensely (Fig. 5I). Ameloblastin continued to be
detected within the ameloblasts as maturation proceeded, with
relatively little staining present in the underlying enamel
matrix (Fig. 5J–L). In Amelx
Y/Y64H and Amelx
Y64H/Y64H
mice, ameloblastin staining within the ameloblasts appeared
to accumulate throughout the secretory zone, with strong
staining towards the proximal pole of the cells. In contrast,
ameloblastin staining was very weak in the newly secreted
enamel matrix (Fig. 5M). In those regions where the amelo-
blasts were severely disorganized, strong ameloblastin staining
was observed both within the multi-cellular masses and within
the enamel matrix (Fig. 5N–P). Amelx
X/Y64H mice displayed a
staining pattern that was intermediate between that seen in WT
mice and that observed in Amelx
Y/Y64H and Amelx
Y64H /Y64H
mice (Supplementary Material, Fig. S2).
Resin histology and immuno-electron microscopy of the
enamel organ and developing enamel of M100888 mutant
mice
Theincreasedeosinophiliaandamelogeninimmunoﬂuorescence
intensity within the secretory ameloblasts of Amelx
Y/Y64H mice
prompted us to explore their morphology in greater detail.
Haematoxylin and eosin-stained, semi-thin resin sections of
the secretory zone of WT mice showed very little eosinophilia
Figure 4. Histological analysis of the lower incisor teeth. (A) Diagrammatic representation of the mouse lower incisor tooth within the mandible. As indicated in
black, enamel production commences at the apical region of the tooth and proceeds towards the incisal edge. (B–E) The secretory, transition, maturation and
post-maturation stages of amelogenesis showed characteristically normal morphology in the WT lower incisor tooth. (F) The secretory ameloblasts of hemizy-
gous male (Amelx
Y/Y64H) mutant mice differentiated normally but soon lost contact with the newly secreted enamel matrix and became abnormally eosinophilic.
(G and H) In the transition and maturation zones, the ameloblasts of Amelx
Y/Y64H mice adopted a highly abnormal morphology and formed irregular, multi-
cellular masses. In these regions, large quantities of amorphous material containing cellular debris (asterisks) were apparent. (I) The multi-cellular masses fre-
quently persisted through the post-maturation zone to the gingival margin. (J) Although the secretory ameloblasts of heterozygous female (Amelx
X/Y64H) mutant
mice appeared largely normal, a proportion exhibited increased eosinophilia. (K and L) In the transition and maturation zones, contact of the ameloblasts with the
enamel matrix was occasionally lost leading to the formation of blister-like structures. (M) In contrast, the appearance of the post-maturation ameloblasts
resembled that of WT mice. m, enamel matrix; a, ameloblasts. Scale bars, 50 mm.
Human Molecular Genetics, 2010, Vol. 19, No. 7 1235Figure 5. Amelogenin and ameloblastin distribution in Amelx mutant mice. (A–H) Amelogenin distribution. (A) Strong amelogenin immunolabelling of the
enamel matrix, arranged as closely packed parallel lines, was observed in the secretory zone of WT mice. (B) Enamel matrix degradation commences in the
transition zone and this was reﬂected in the WT enamel matrix where the intensity of immunostaining was markedly reduced. (C) Little amelogenin immunor-
eactivity was detected in the maturation zone where the process of enamel matrix degradation is completed. (D) No amelogenin immunoreactivity was observed
in the post-maturation enamel matrix. (E) In the secretory zone of hemizygous male (Amelx
Y/Y64H) mutant mice strong amelogenin immunolabelling of the
enamel matrix was observed; however, the pattern of parallel lines observed in WT mice was lost. Additionally, the secretory ameloblasts of Amelx
Y/Y64H
mice showed increased immunostaining in the cytoplasm. (F and G) Where the ameloblasts became disorganized in Amelx
Y/Y64H mice, strong amelogenin immu-
nostaining was detected both in the enamel matrix and within the multi-cellular masses (asterisk). (H) Amelogenin immunoreactivity was often detected in the
post-maturation zone where enamel matrix is normally absent. (I–P) Ameloblastin distribution. (I) In the secretory zone of WT mice, strong ameloblastin immu-
nostaining of the enamel matrix was detected in the vicinity of the ameloblast Tomes’ processes. Strong ameloblastin immunoreactivity was also observed in the
supranuclear compartment of the secretory ameloblasts. (J–L) Ameloblastin expression in the cytoplasm of WT ameloblasts was detected throughout the sub-
sequent stages of amelogenesis. (M) In hemizygous male (Amelx
Y/Y64H) mutant mice, the secretory ameloblasts were immunoreactive for ameloblastin; however,
the regular pattern of supra-nuclear immunoreactivity observed in WT mice was replaced by patchy aggregates of ameloblastin immunostaining. Immunolabel-
ling of the enamel matrix was very weak in Amelx
Y/Y64H mice. (N and O) Where the ameloblasts became disorganized in those regions corresponding to the
transition and maturation zones of WT mice, intracellular ameloblastin immunostaining became more intense in Amelx
Y/Y64H mice. (P) Extracellular ameloblas-
tin immunoreactivity was frequently observed in the post-maturation stage of enamel formation in Amelx
Y/Y64H mice. m, enamel matrix; a, ameloblasts. Scale
bars, 50 mm.
1236 Human Molecular Genetics, 2010, Vol. 19, No. 7in the ameloblasts with a regular ‘herring-bone’ pattern corre-
sponding to the insertion of the Tomes’ processes into the
strongly stained enamel matrix (Fig. 6A). Examination of
similar sections from Amelx
Y/Y64H mice revealed strong eosino-
philia within many of the ameloblasts (Fig. 6B and C). These
eosinophilic structures were visible throughout the cell and
appeared to be vesicular in nature. At the interface of the amelo-
blasts and enamel matrix the regular pattern of Tomes’ process
insertions was absent but showed a disorganized vesicular
pattern (Fig. 6B) or contact of the ameloblasts with the enamel
matrix was often lost leading to the formation of out-pocketings
containing eosinophilic material (Fig. 6C). Immuno-electron
microscopy using an antibody against amelogenin indicated
that the affected secretory ameloblasts were engorged with
amelogenin-containing vacuoles (Fig. 6D).
Further characterization of the enamel organ in M100888
mutant mice
To characterize further the disorganized, multi-cellular




tin was carried out. Additionally, immunodetection of keratins
was performed in conjunction with bromodeoxyuridine
(5-bromo-2-deoxyuridine) (BrdU) and terminal deoxynucleoti-
dyl transferase dUTP nick end labelling (TUNEL)/caspase-3
Figure 6. Acrylic resin histology and immunoelectron microscopy. (A) Semi-thin, transverse sections of the secretory zone of WT mice revealed pale-staining
ameloblasts and an intensely eosinophilic, enamel matrix. The interdigitations of the ameloblast Tomes’ processes were clearly evident in the region where new
enamel matrix was forming (arrows). (B and C) In hemizygous male (Amelx
Y/Y64H) mutant mice, many of the ameloblasts contained large numbers of eosino-
philic vesicles (arrowheads). Although the enamel matrix was intensely eosinophilic as observed in WT mice, it was highly disorganized (asterisk) and contact
with the ameloblasts was lost. (C) Where new enamel matrix was being secreted, the interdigitating pattern seen in WT mice was replaced by large vacuolar
structures (arrows). (D) Immunoelectron microscopy of Amelx
Y/Y64H secretory ameloblasts revealed the cytoplasm to be engorged by vacuoles of up to 2 mm
diameter which were present in such large numbers that they led to the ameloblast nuclei becoming distorted. These vacuoles were strongly immunoreactive
(black dots) for amelogenin (inset). m, enamel matrix; a, ameloblasts; n, nuclei. Scale bars in A–C, 25 mm and in D, 2 mm.
Human Molecular Genetics, 2010, Vol. 19, No. 7 1237staining to determine cell proliferation and apoptosis, respect-
ively. In WT mice, cells of ectodermal origin (ameloblasts,
stratum intermediumandpapillary layer) were immunoreactive
for a pan-keratin antibody although those cells derived from the
mesenchyme(ﬁbroblasts,vascularendothelia)stainedpositively
for vimentin (Supplementary Material, Fig. S3A and B). Immu-
nohistochemistry using both antibodies in Amelx
Y/Y64H and
Amelx
Y64H/Y64H mice revealed both pan-keratin and vimentin-
positive cells within the abnormal multi-cellular masses; these
appeared tobelocalized within distinct cellular cohorts consist-
ent with their developmental origins (Supplementary Material,
Fig. S3C–E). In WT mice, although occasional BrdU-positive
cells were observed within the mesenchymally derived
tissue compartment deﬁned above, they were not detected
in the enamel organ (Fig. 7A). This was also the case for
Amelx
Y/Y64H and Amelx
Y64H/Y64H mice (Fig. 7B). At the point
where the multi-cellular masses begin to form within the
enamel organ of the Amelx
Y/Y64 H mice, cellular debris was
observed suggesting that many of the ameloblasts were dying.
Apoptotic ameloblast cell death is usual in the enamel organ of
WT mice; some 25% are lost during the transition stage and a
further25% arelostduringthematurationstageofamelogenesis
(22). To investigate whether the increased celldeath observed in
Amelx
Y/Y64H mice was apoptotic, we performed TUNEL assays
and immunolabelling for activated caspase-3 (Fig. 7C–F).
Examination of ameloblasts within the transition zone of WT
mice revealed occasional TUNEL-positive nuclei and cells
labelled strongly for activated caspase-3 (Fig. 7C and E). In
Amelx
Y/Y64H mice, much of the cellular debris was either
TUNEL- or activated caspase-3-positive (Fig. 7D and F). Fur-
thermore, the ameloblasts immediately proximal to the area of
observable cell death were frequently immunoreactive for
activated caspase-3.
Effect of the amelogenin Y64H mutation on the pattern of
the developing enamel matrix proteome
SDS PAGE and subsequent Western analysis with anti-
amelogenin antibodies (Fig. 8B) revealed that the developing
enamel matrix proteome was atypical for both Amelx
X/Y64H and
Amelx
Y/Y64H animals. WT controls showed the characteristic
pattern of rodent amelogenin proteins, with components
migrating at apparent molecular weights of between 5 and
31 kDa. The larger amelogenins (26–31 kDa) correspond to a
Figure 7. Analysis of cell proliferation and apoptosis. (A) Pan-cytokeratin (green) and BrdU (red) dual immunolabelling of the enamel organ of WT mice
showing occasional BrdU-positive nuclei (arrowheads), conﬁned to the underlying connective tissue compartment. (B) In the multi-cellular masses observed
in hemizygous male (Amelx
Y/Y64H) mutant mice, BrdU-positive nuclei remained conﬁned to the connective tissue element (arrowheads). (C) TUNEL-positive
nuclei (arrowheads) were observed in the transition zone of WT mice. (D) In hemizygous male (Amelx
Y/Y64H) mutant mice, numerous TUNEL-positive nuclei
(arrowheads) were observed in the amorphous material associated with the multi-cellular masses. (E) Immunolabelling for activated caspase 3 in WT mice
revealed strong immunoreactivity in transition stage ameloblasts (arrowheads). (F) The ameloblasts immediately proximal to the area where multi-cellular
masses form in Amelx
Y/Y64H mice were strongly immunoreactive for activated caspase 3 (arrowheads). The arrows in (C) and (E) indicate autoﬂuorescence
from erythrocytes. a, ameloblasts; p, stratum intermedium/papillary layer complex; ct, connective tissue. Scale bars in A–C and E, 50 mm and in D and F,
25 mm.
1238 Human Molecular Genetics, 2010, Vol. 19, No. 7spectrum of nascent molecules generated by alternative splicing
(Fig. 8A and B). Most of the lower molecular weight molecules
are the result of extracellular enzymatic processing of




processing products (Fig. 8A). Matrix proteins extracted
from Amelx
X/Y64H mice showed a protein proﬁle between that
of WT and affected male mice (Fig. 8A and B).
To determine whether the observed lack of high molecular
weight amelogenins in the developing enamel of Amelx
Y/Y64H
animals was due to differential proteolytic processing of the
mutant protein, recombinant WT and Y64H mutant amelogen-
ins were expressed, isolated and puriﬁed. Western blotting
coupled with mass spectroscopy of the prepared recombinant
proteins conﬁrmed their identities. SDS–PAGE showed that
both WT and Y64H mutant amelogenins migrating at
29 kDa were similarly degraded over 24 h in the presence of
secretory stage enamel extract enriched with MMP-20 (‘enam-
elysin’; Fig. 8C).
Effect of the amelogenin Y64H mutation on amelogenin–
amelogenin interactions
Amelogenin forms self-assembled structures (‘nanospheres’)
in vivo and in vitro (23,24). We used a near-neighbour, cross-
linking strategy to determine any gross effects of the Y64H
mutation on amelogenin–amelogenin interactions and found
that no effects were discernible between Y64H and WT
recombinant amelogenin behaviour. Both WT and Y64H
Figure 8. Biochemical investigations relating to the Y64H developing enamel proteome. (A) SDS–PAGE of secretory stage developing enamel removed from
WT and Y64H mouse mandibular incisors showing apparent lack of full-length amelogenin proteins in the mutant animals (arrowed). Male and female WT
animals had clear evidence of higher molecular weight amelogenins migrating up to 30 kDa. Y64H affected males had no proteins corresponding to this mol-
ecular weight range. Female mice, heterozygous with respect to the Y64H mutation did have higher molecular weight amelogenin present but at reduced amounts
compared with WT. (B) Western blot of secretory stage developing enamel removed from WT and Y64H mouse mandibular incisors conﬁrming the apparent
lack of full-length amelogenin proteins (arrowed) in the mutant animals observed by SDS–PAGE (A). (C) SDS–PAGE of WT and Y64H recombinant ame-
logenins before and after incubation with secretory enamel protease extracts. After 24 h, Coomassie Blue staining revealed clear evidence of proteolytic degra-
dation for both recombinant proteins, with progressive loss of intact protein (SDS Mr ¼ 29 kDa). Proteins migrating at 70–80 kDa and around 20 kDa were also
present in the MMP20 extracts and can be ignored with regard to the degradation of the recombinants. (D) SDS–PAGE of WT and Y64H recombinant ame-
logenins subjected to near-neighbour molecular cross-linking. Both WT and Y64H recombinant amelogenins were cross-linked to form supra-molecular com-
plexes that failed to penetrate the SDS–PAGE stacking gel. On reduction of the cross-links, the amelogenins forming these complexes were returned to their
monomeric state migrating at around 29 kDa.
Human Molecular Genetics, 2010, Vol. 19, No. 7 1239recombinant amelogenins were cross-linked to form supra-
molecular complexes that failed to penetrate the SDS–
PAGE stacking gel (Fig. 8D). On reduction of the cross-links,
the amelogenins forming these complexes were returned to
their monomeric state migrating at around 29 kDa (Fig. 8D).
Effect of the Y64H mutation on amelogenin mRNA
expression
In situ hybridization. To investigate whether the Y64H
mutation affected amelogenin expression, we performed
in situ hybridization using an amelogenin riboprobe corre-
sponding to the full-length (excluding exon 4) transcript. In
WT lower incisors, amelogenin mRNA was observed within
the secretory ameloblasts and persisted into the early
maturation stage ameloblasts after which its expression
ceased abruptly (Supplementary Material, Fig. S4A). In
Amelx
Y/Y64H mice, amelogenin mRNA expression showed a
similar pattern extending to a region analogous to that of
early maturation seen in WT mice (Supplementary Material,
Fig. S4B).
RT–PCR. Our results using in situ hybridization suggested
that the lack of high molecular weight amelogenin in the
developing enamel matrix of Y64H affected animals was not
due to lack of amelogenin expression in the enamel organ.
However, to determine whether full-length transcripts of ame-
logenin were present, RT–PCR was also carried out. The
results showed no differences in transcript length between
animals containing the Y64H mutation and their WT litter-
mates (Supplementary Material, Fig. S4C). Transcripts corre-
sponding to the predicted size of the major, full-length
amelogenin transcript were clearly seen in the Amelx
Y/Y64H
mice [including a transcript corresponding to alternatively
spliced transcripts containing exon 4 (25)].
Effect of Y64H amelogenin on epithelial cell survival
To investigate potential effects of the Y64H mutation on cell
survival, we transfected COS-7 cells with expression vectors
containing WT and Y64H amelogenin cDNAs (Fig. 9).
Additionally, in light of the retention of ameloblastin in the
ameloblasts of M100888 mutant mice (Fig. 5M–O), we also
Figure 9. Effect of the Y64H mutant amelogenin on cell survival. (A) COS-7 cell transfected with the WT amelogenin construct. The cell shows strong ame-
logenin expression (red ﬂuorescence) and appears large and viable. (B) A similar cell transfected with Y64H amelogenin construct showing strong amelogenin
expression (red ﬂuorescence) is also typically large and viable. (C) A cell co-transfected with WT amelogenin and ameloblastin constructs shows strong immu-
nolabelling for both proteins (orange–yellow ﬂuorescence) and also appears large and viable. (D) Cells co-transfected with Y64H mutant amelogenin and ame-
loblastin constructs (orange–yellow ﬂuorescence) were typically small with a condensed nucleus (blue) consistent with apoptosis. (E and F) TUNEL analysis of
cells transfected with (E), mutant amelogenin alone and (F), mutant amelogenin and ameloblastin constructs. To improve discrimination of apoptotic cell nuclei,
the images of the cells subjected to TUNEL analysis were pseudo-coloured such that TUNEL-positive nuclei appear red (arrows) and normal nuclei appear
yellow. Scale bars represent 10 mm. (G) Results of TUNEL assays on four replicate experiments of each transfection/co-transfection. One-way ANOVA fol-
lowed by a Bonferroni multiple comparison test showed that the large increase in mean percentage of TUNEL-positive nuclei detected in the Y64H mutant
amelogenin/ameloblastin co-transfections was statistically signiﬁcant (P , 0.0001) compared with cells transfected with Y64H mutant amelogenin alone. No
statistically signiﬁcant difference in the incidence of apoptosis could be shown between cells transfected with WT amelogenin alone and those co-transfected
with WT amelogenin and ameloblastin.
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cells. Both WT and Y64H amelogenin were expressed in
transfected cells, which were generally viable (Fig. 9A and
B). Similarly, ameloblastin expression and co-expression of
WT amelogenin and ameloblastin did not lead to a marked
reduction in cell viability (Fig. 9C). In contrast, large
numbers of cells with condensed nuclei were observed follow-
ing co-transfection with ameloblastin and Y64H amelogenin,
suggesting that cell survival was compromised (Fig. 9D). In
light of these observations, we determined the incidence of
apoptosis in transfected cells using the TUNEL assay
(Fig. 9E and F). Comparison of cells singly transfected with
WT amelogenin and those co-transfected with WT amelogenin
and ameloblastin revealed no statistically signiﬁcant differ-
ence in the mean percentage of TUNEL-positive cell nuclei
(Fig. 9G). In contrast, comparison of cells singly transfected
with Y64H amelogenin and those co-transfected with Y64H
amelogenin and ameloblastin revealed a statistically signiﬁ-
cant (P , 0.0001) increase in the mean percentage of
TUNEL-positive nuclei (Fig. 9G).
DISCUSSION
Human X-linked AI is associated predominantly (although not
exclusively) with mutations in the AMELX gene which
encodes the enamel extracellular matrix protein amelogenin
and some 15 mutations have been described to date (4). In
general, mutations predicted to cause a total loss of amelo-
genin function, for example signal peptide mutations, or
mutations causing loss of the amelogenin C-terminus, result
in enamel hypoplasias, although mineralization defects may
also occur (14). In contrast, although only a small number of
mis-sense mutations have been described, those which affect
the N-terminal region, especially those causing changes in
the tyrosine-rich (TRAP) region of amelogenin, result in a pre-
dominantly hypomineralization/hypomaturation AI pheno-
type. In these cases, mature enamel may retain amelogenin
and be discoloured. Understanding the relationship between
phenotype and underlying genetic lesion is made more
complex by the extensive alternative splicing of AMELX
such that a point mutation could potentially affect several
different amelogenin proteins but have no effect on others.
Despite the progress that has been made in determining the
genetic basis of X-linked AI, the underlying molecular
pathology remains poorly characterized. This is due to the
paucity of available teeth from affected individuals suitable
for biochemical and histological examination and the difﬁculty
of obtaining developing human dental tissues. Mouse
models are therefore an essential resource for furthering our
understanding of the role of amelogenin in enamel bio-
mineralization. Analysis of amelogenin-null mice has demon-
strated that although ameloblast differentiation is normal, the
resulting enamel is hypoplastic, appearing as an abnormally
thin layer that lacks the highly organized prismatic structure
characteristic of the mature tissue, suggesting that amelogenin
is essential for the control of enamel bio-mineralization, struc-
ture and thickness (9,26). In this respect, the amelogenin-null
mouse combines the various human phenotypes into a single
model (9).
In the current article, we report the novel mis-sense
mutation Y64H in amelogenin as underlying the AI phenotype
observed in mice obtained as part of a large-scale ENU
mutagenesis programme (http://www.gsc.riken.jp/Mouse/).
The Y64H mutation occurs within the conserved tri-tyrosyl
motif (PYPSYGYEPMGGW) of amelogenin which binds
to N-acetyl-D-glucosamine and is positioned towards the
C-terminus of the TRAP region (15). In humans, a P ! T
mutation, which also lies in this domain, underlies a unique
but consistent AI phenotype in three families (14,16,27).
Our results show that the murine Y64H mutation results in
enamel that is hypomineralized in the case of Amelx
X/Y64H
mice or severely hypoplastic in the case of Amelx
Y/Y64H and
Amelx
Y64H/Y64H animals indicating that the M100888 mutant
mice phenocopy AI patients presenting with a P ! T mutation
in the tri-tyrosyl motif of amelogenin.
Large areas of enamel were missing from the teeth of Y64H
homozygotes (both Amelx
Y/Y64H males and Amelx
Y64H/Y64H
females), though the mineral levels in the enamel that
remained were within the normal range; however, the ultra-
structural appearance was severely dysplastic. It is unclear
whether the apparent loss of enamel from these teeth results
from post-eruptive breakdown or whether this is a primary
developmental defect. Our preliminary investigations using
nano-CT scanning of unerupted teeth suggests the latter
(data not shown). The physical properties of dental enamel
are closely associated with its structure and prismatic organiz-
ation. Previous studies have shown that nascent amelogenin
localizes to prism cores in the newly secreted enamel (28)
suggesting a role in mineral organization. Using SDS–
PAGE and Western analysis, we failed to demonstrate the
presence of full-length nascent amelogenin within the
secretory stage matrix of Amelx
Y/Y64H teeth. The lower mol-
ecular weight amelogenin components detected in these
animals are likely to reﬂect proteins arising from differentially
spliced Amelx transcripts, the most abundant of which is
thought to be the leucine-rich amelogenin peptide (LRAP).
LRAP would not contain the Y64H mutation due to splicing
out of the 50 end of exon 6 containing this mutation.
The lack of full-length amelogenin in the developing
enamel matrix of affected animals suggested therefore that
the observed bio-mineralization defects could be due to (i)
failure to express full-length amelogenin containing the
Y64H mutation; (ii) impaired secretion of Y64H amelogenin
or (iii) an unusually high extracellular degradation rate for
amelogenins carrying this mutation. Both in situ hybridization
and RT–PCR indicated that full-length amelogenin was
expressed by ameloblasts in Amelx
Y/Y64H mice, eliminating
failure to express this transcript as a possible pathogenic
mechanism. Our preliminary degradation studies using recom-
binant WT and Y64H mutant amelogenins incubated with
MMP20 extracts showed no gross differences in degradation
rate or pattern of resulting degradation products at the time
intervals used. This is in contrast to previous reports that
showed amelogenin hydrolysis to be compromised as a
result of a P ! T mutation in this same domain (17). Our
data tend to eliminate the possibility that the Y64H mutation
increases the susceptibility of Y64H amelogenin to normal
post-secretory processing and enhanced sensitivity to extra-
cellular proteolysis does not appear to be a mechanism
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esize that the paucity of full-length Y64H amelogenin in the
Y64H mutant enamel matrix results from a failure to success-
fully trafﬁc and secrete amelogenin into the enamel matrix.
Our immunohistochemical data indicate that both amelogenin
and ameloblastin accumulate within the ameloblasts of
affected mice and that these accumulations become increas-
ingly marked as amelogenesis proceeds. Transmission electron
microscopy further conﬁrmed this ﬁnding, clearly showing
ameloblasts with abnormal cell morphology and engorged
endoplasmic reticulum/Golgi apparatus heavily immunola-
belled with an anti-amelogenin antibody, indicating intracellu-
lar retention of Y64H amelogenin.
In light of the impaired secretion of amelogenin and amelo-
blastin in M100888 mutant mice, we analysed the effects of
WT amelogenin, Y64H mutant amelogenin and ameloblastin
expression, both singly and in combination, in a transfected
eukaryotic cell line of epithelial origin. This approach is rel-
evant since amelogenin has been shown to interact directly
through its tri-tyrosine motif with native and recombinant
ameloblastin (29). In addition, ameloblastin and amelogenin
share a common secretory pathway and co-localize within
identical secretory granules within ameloblasts (30) where
they may interact. Co-expression of Y64H mutant amelogenin
and ameloblastin in our transfected epithelial cell lines
resulted in a marked decrease in cell survival compared with
when the three proteins were transfected in isolation or
when WT amelogenin and ameloblastin were co-transfected.
This observation suggests that a combination of Y64H
mutant amelogenin and ameloblastin is a pathological factor
in these transfected cells that might also be present in vivo
in the M100888 mutants. The precise mechanism by which
Y64H amelogenin in combination with ameloblastin leads to
decreased cell survival in our transfection experiments is
unclear but it could be due to Y64H amelogenin–ameloblastin
interactions resulting in complexes that can be no longer traf-
ﬁcked appropriately prior to secretion due to conformational
anomalies. The accumulating protein could then lead to ER
stress and cell death.
Mice expressing a truncated ameloblastin (lacking exons 5
and 6), share similar histopathological features to the Y64H
amelogenin mutant mice reported here (8,31). The ameloblasts
of these mice lose contact with their meagre enamel matrix
during the secretory stage of amelogenesis and become disor-
ganized, forming multi-cellular masses often enclosing iso-
lated accretions of matrix-like material. This raises the
possibility that the M100888 mutant phenotype may be due
in part to disturbances involving ameloblastin secretion and
function that normally rely on amelogenin–ameloblastin inter-
actions—these interactions being compromised in the pres-
ence of Y64H mutant amelogenin.
What is certain is that biological interplay between amelo-
genin and ameloblastin appears to be necessary to sustain ame-
loblasts during the secretory stage of amelogenesis. In mice
null for both amelogenin and ameloblastin the deleterious
effect on enamel formation was greater than in mice null for
amelogenin alone or null for ameloblastin alone suggesting a
synergistic role for these proteins in amelogenesis (32).
Taken together, these data suggest that the ameloblasts in
M100888 mutant mice endure a secretory defect which
impairs not only the secretion of amelogenin but also that of
ameloblastin. The impairment of ameloblastin secretion may
be responsible for the altered behaviour of the ameloblasts
in the Y64H amelogenin mutant mouse acting similarly to
the loss-of-function mutation in the Ambn mutant mouse.
It is also plausible that the retention of both proteins within
ameloblasts would induce cellular stresses which culminate
in the extensive apoptosis we observed in the Y64H mutant
mouse; a phenomenon that is clearly modelled by our transfec-
tion studies.
However, when considering amelogenin–ameloblastin
interactions and their potential role in amelogenesis in vivo,
the relative abundances of the two proteins must be con-
sidered. The intra-cellular concentrations of amelogenin and
ameloblastin are unknown but there is a huge excess of
amelogenin over ameloblastin in the extracellular matrix. It
is therefore conceivable that the synthesis of both proteins
differs commensurately and that most amelogenin remains
un-associated with the much scarcer ameloblastin in
the intracellular secretory pathway. Abnormal amelogenin–
ameloblastin interactions may therefore be only one part of
the reason for impairment of secretion in Y64H mutant
mice. Other protein–protein interactions may also be affected,
including amelogenin–cytokeratin interactions. The tri-tyrosyl
motif has been shown to bind to a conserved N-acetyl-
D-glucosamine mimicking sequence present in cytokeratin 14
(33) and N-acetyl-D-glucosamine residues on cytokeratin 5
(19). Amelogenin and cytokeratin 14 co-localize at the
apical regions of ameloblasts and dissociate at the Tomes’ pro-
cesses prior to secretion leading to suggestions of a possible
role for cytokeratin 14 in chaperoning amelogenin during ame-
logenesis (19,33). Failure to bind cytokeratin 14 was demon-
strated when the human P ! T mutation was introduced
into the amelogenin tri-tyrosyl motif or when all three tyrosine
residues were replaced by phenylalanine (33). It is therefore
possible that the Y64H mutation also affects binding
between amelogenin and cytokeratin 14 which is necessary
for amelogenin secretion. Whether either or both of these
possible mechanisms is driving phenotype in the Y64H
mutant mice, we suggest that failure to secrete matrix proteins
would lead to cell stress and disruption of normal ameloblast
organization and behaviour.
In this study, we have shown here that abnormal retention of
matrix components within the ameloblasts is coincident with
loss of ameloblast organization and appearance of multi-
cellular masses, frequently associated with tissue necrosis, in
the Y64H animals. Analysis of cell proliferation showed that
increased cell proliferation was a feature of the surrounding
connective tissue rather than the ameloblasts themselves.
Investigations of cell death revealed a pronounced loss of ame-
loblasts associated with apoptosis at around the point where
the multi-cellular masses began to form. This massive loss
of ameloblasts was seen histologically as a region of necrosis.
The increased proliferation within the surrounding connective
tissue may therefore be a pathological reaction to this necrosis
leading to the observed connective tissue invasion and ﬁbrosis
of the persisting enamel matrix. Such ﬁbrosis is a well-known
occurrence in many chronic, necrotizing pathologies (34–37).
The presence of multi-cellular masses in the jaws of the
M100888 mice reported here has also been observed in
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amelogenin tri-tyrosyl motif (38), further paralleling the Y64H
mutation with that found in humans.
We predict that the Y64H amelogenin mutation results in a
failure to trafﬁc and secrete protein along the usual pathways
resulting in the observed accumulation of amelogenin and
ameloblastin in the ameloblast endoplasmic reticulum. This
could be due to one of two different mechanisms: the presence
of the Y64H mutation in the amelogenin tri-tyrosyl domain
could preclude normal chaperoning and intracellular trafﬁck-
ing. Our preliminary results using recombinant Y64H and
WT amelogenins show that amelogenin–amelogenin near
neighbour interactions are similar. It is therefore possible
that other protein–protein binding, including ameloblastin–
amelogenin binding and/or cytokeratin–amelogenin binding,
is necessary to prevent intracellular amelogenin self-assembly
which in turn would lead to secretory failure. Other examples
of this in man include the premature oligomerization of
mutated forms of myelin proteolipid protein in the endoplas-
mic reticulum, shown to cause secretory failure and resulting
in dysmyelinating disease (39).
In summary, we describe here a mis-sense mutation in the
murine Amelx tri-tyrosyl domain of the enamel extracellular
matrix protein amelogenin that phenocopies human X-linked
AI where similar mutations have been reported in the same
sequence. Animals affected by the mutation have severe
enamel bio-mineralization defects associated with absence of
full-length amelogenin protein in the developing enamel
matrix, loss of ameloblast phenotype, increased ameloblast
apoptosis and formation of multi-cellular masses. We
present evidence to demonstrate that affected ameloblasts
express but fail to secrete amelogenin leading to ER/Golgi
engorgement and hypothesize that this is a key mechanistic
factor underpinning the pathology. This study therefore suc-
cessfully links phenotype with underlying genetic lesion in a
relevant murine model for human AI.
MATERIALS AND METHODS
Source of material and gene sequencing
The mutant mouse line M100888 was obtained from RIKEN
GSC (http://www.gsc.riken.jp/Mouse/) and maintained on a
DBA/2J genetic background. To search for the causative
mutation, we designed oligonucleotide primer sequences based
on the genomic sequence of Amelx (ENSMUSG00000031354)
and sequenced each exon and the associated splice junctions
using dye primer chemistry. The sequences obtained were com-
pared with those generated from a panel of inbred strains (A/J,
AKR/J, BALB/c, C57BL/6J, CAST/Ei, CBA/J, DBA/2J and
SPRET/Ei). All experiments were performed in accordance
with the Animals (Scientiﬁc Procedures) Act, UK, 1986.
Preparation of teeth for microradiography and scanning
electron microscopy
Lower incisors were dissected from 2- to 3-month-old, WT,
hemizygous (Amelx
Y/Y64H) mutant male and heterozygous
mutant females (Amelx
X/Y64H) mice (n ¼ 3 in each category).
Adherent soft tissue was removed and the incisors freeze-dried
and embedded in methyl methacrylate. The embedded teeth
were sectioned transverse to the long axis of the tooth using
an Accutom-5 cutter with a peripheral diamond cutting disc
and minimal water cooling to minimize loss of organic com-
ponents within the enamel. Sections were taken at points cor-
responding to the end of secretion, maturation and fully
mature enamel and polished plano-parallel with 1200 grade
carborundum paper to a thickness of 100 mm (ﬁnal thickness
being determined by micrometer measurement) then acid-
etched for 15 s with 35% phosphoric acid to remove the
smear layer and thoroughly washed in distilled water (pH 7.0).
Quantitative determination of enamel mineral density
Mineral density was determined across the full thickness of
enamel within the sections using transverse microradiography
(TMR) as described previously (40). Brieﬂy, sections were
contact microradiographed for 6 min on Kodak High Resol-
ution plate, type 1A, by Ni-ﬁltered Cu–K radiation at
20 kV, 4 mA. An aluminium step wedge was included to aid
quantitation. The microradiographs were developed in
Kodak HRP developer and analysed by TMRW software
(version 20.0.27.16, 2000; Inspektor Research Systems, The
Netherlands). The enhanced images of the microradiographs
were analysed under standard conditions of light intensity
and magniﬁcation and were processed, along with data from
measurement of the aluminium step wedge, by the TMR
program. Mineral density levels were compared, where poss-
ible, using one way ANOVA.
Ultrastructural appearance of enamel
Following microradiography, the sections were mounted on
aluminium stubs and sputter-coated with gold. Microstructural
analysis was undertaken using a Jeol 35 SEM ﬁtted with the
Deben ‘Genie’ upgrade (Deben Engineering, UK).
Histological and immunoﬂuorescence analysis of the
enamel organ and developing enamel
Mandibles from 2- to 3-month-old hemizygous mutant male,
heterozygous mutant female, homozygous mutant female
and WT male mice (n ¼ 4 in each category) were dissected
following cervical dislocation and ﬁxed in neutral buffered
formalin at room temperature for 48 h. Following ﬁxation,
the mandibles were decalciﬁed in 5% EDTA, dehydrated
through a graded ethanol series, cleared in chloroform,
embedded as hemi-mandibles in parafﬁn wax, sectioned and
stained with haematoxylin and eosin. Sections were examined
using a DMRB microscope (Leica) with SpotTM digital camera
and associated software (RTKE/SE Diagnostic Instruments
Inc.). Immunoﬂuorescence analysis was performed on mand-
ibles prepared as above using antibodies raised against acti-
vated caspase 3 (Abcam), amelogenin (FL191, Santa Cruz
Biotechnology) and ameloblastin (C17, Santa Cruz Biotech-
nology). Primary antibodies were detected using biotinylated
secondary antibodies (Vector laboratories) followed by
Cy-3-conjugated streptavidin (Sigma) and mounted in ﬂuor-
escence mountant containing DAPI (Vector laboratories). The
TUNEL assay was performed according to the manufacturer’s
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examined as above.
High-resolution histology and immuno-electron
microscopy
Hemi-mandibles dissected from WT and hemizygous mutant
male mice (n ¼ 3) were ﬁxed in 4% paraformaldehyde in
0.1 M cacodylate buffer (pH 7.4) overnight at 48C, rinsed in
PBS and decalciﬁed as described above. Following decalciﬁ-
cation, samples were re-ﬁxed with 4% paraformaldehyde in
0.1 M cacodylate buffer (pH 7.4) overnight. The next
morning, samples were dehydrated through a graded ethanol
series and embedded as transverse segments corresponding
to the secretory and maturation regions of the tooth in
acrylic resin (LR White) and polymerized at 408C for 24 h.
Semi-thin sections were prepared using a glass knife,
mounted on Superfrost Plus glass slides (Thermo Shandon),
stained with haematoxylin and eosin and examined as above.
Ultrathin sections were cut with a Diatome diamond knife
on a Reichert-Jung Ultracut microtome and were mounted
on formvar/carbon-coated copper grids. For immunolabelling,
grids were incubated with blocking solution (1% bovine serum
albumin, 0.15 M glycine, 0.1% Tween-20, 0.1 M phosphate
buffer, pH 7.4) for 15 min, then with primary antibody to ame-
logenin (FL191, Santa Cruz Biotechnology) for 1 h, then with
secondary antibodies conjugated with 10 nm gold particles for
30 min and washed extensively with distilled water. Sections
were contrasted with 1% uranyl acetate for 10 min and
observed using an FEI Tecnai 12 Biotwin electron microscope
(FEI company, The Netherlands) at an accelerating voltage of
100 kV.
Determination of amelogenin expression by in situ
hybridization
Amelogenin cDNA was cloned into pBluescript II SK (Strata-
gene) and the resulting construct used to synthesize a
digoxygenin-labelled, amelogenin antisense riboprobe using
T7 polymerase (Promega) and digoxygenin-conjugated
dUTP (Roche). In situ hybridization was performed as
described previously (41,42), however, riboprobe binding
was detected immunohistochemically using an alkaline
phosphatase-conjugated, anti-digoxygenin antibody (Roche)
followed by histochemical demonstration of alkaline phospha-
tase activity using BM purple (Roche) as the chromogenic
substate.
Determination of ameloblast cell proliferation using BrdU
labelling
Cell proliferation was detected by intra-peritoneal injection of
BrdU labelling reagent (Amersham Biosciences) at 100 mg/g
body weight, into 2–3-month-old, WT and hemizygous
mutant male mice (n ¼ 4). The mice were killed by cervical
dislocation 2 h later and their mandibles processed for histo-
logical analysis as described above. Sections were immunola-
belled using an antibody against BrdU (Abcam) following
retrieval in 10 mM sodium citrate (pH 6.0) and detected
using a biotinylated secondary antibody (Vector laboratories)
and Cy3-conjugated streptavidin (Sigma). A pan-cytokeratin
antibody (Neomarkers) was used to detect epithelial elements
in the same sections and detected with a ﬂuorescent secondary
antibody (AlexaFluor 488, Molecular Probes).
SDS–PAGE analysis and western blotting
WT, hemizygous Amelx
Y/Y64H mutant male mice and
Amelx
X/Y64H heterozygous female mice were killed by cervi-
cal dislocation and the mandibles removed. The contralateral
incisors were dissected from the mandibular bone and the
enamel organs wiped away with damp paper tissue. After
1 min, the white opaque zone indicative of the maturation
stage became apparent. Contiguous samples of secretory,
early maturation and late maturation stage enamel were
microdissected from the dentine. In this way, results obtained
reﬂect protein per volume of enamel. All samples were stored
at 2808C.
Enamel samples were dissolved in 20 ml of 10% acetic acid.
Once dissolved, 180 ml of SDS sample loading buffer were
added and the samples neutralized by addition of 7.5 mlo f
5 M NaOH. Samples were loaded at 10 ml per lane and sub-
jected to gel electrophoresis (Bio-Rad Protean III) using
15% Tris/glycine gels run at a constant 200 V. Resolved pro-
teins were detected by silver staining. Alternatively, separated
proteins were transferred from the gels to nitrocellulose sheets
and probed using monospeciﬁc, polyclonal antibodies to ame-
logenin (Santa Cruz FL-191). Nitrocellulose membranes were
blocked overnight at room temperature in TBS containing 5%
casein. Membranes were washed brieﬂy in TBS and incubated
for 2 h in rabbit polyclonal anti-full-length amelogenin anti-
bodies. Immuno-reactivity was visualized using an ampliﬁed
alkaline phosphatase detection system (Bio-Rad, Immun-Blot
ampliﬁed AP assay kit) in accordance with the manufacturer’s
instructions.
Expression of recombinant proteins
Full-length WT and Y64H mutant amelogenin proteins were
expressed using a pET28 expression vector (Novagen,
Merck Chemicals Ltd) modiﬁed with a HRV 3C protease
site in Rosetta DE3 Escherichia Coli cells (Novagen). The
cells were harvested by centrifugation and lyzed using a
lysis buffer containing 100 mM NaH2PO4,1 0 m M Tris and
6 M guanidine-HCl (pH 8.0). Expressed proteins were puriﬁed
using nickel afﬁnity chromatography (GE Healthcare HiTrap
Nickel column) in the presence of 8 M urea. The histidine
tag was removed by incubating the protein with HRV 3C pro-
tease (A.G. Scientiﬁc, Inc.) overnight in 50 mM Tris buffer
(pH 8.0) at a concentration of 25 mg/ml. Final puriﬁcation
was achieved by preparative SDS–PAGE (Bio-Rad Model
491 Prepcell) using an 8 cm 12% polyacrylamide gel run at
a constant power of 12 W. Fractions were collected for
3.33 min each at a ﬂow rate of 220 ml/min. Fractions contain-
ing puriﬁed recombinant protein were identiﬁed by standard
SDS–PAGE. Relevant fractions were desalted against
125 mM formic acid using a Hi Prep 26/10 desalting column
(GE Healthcare) and the proteins lyophilized prior to use.
Protein identity was conﬁrmed by western blotting using anti-
amelogenin antibodies as described above. Mass spectroscopy
1244 Human Molecular Genetics, 2010, Vol. 19, No. 7of WT and Y64H recombinant proteins gave molecular masses
of 20 590 and 20 564 kDa, respectively (predicted masses ¼
20 591 and 20 565 kDa, respectively).
Determination of amelogenin–amelogenin interactions
using molecular cross-linking
To compare amelogenin–amelogenin interactions, a near
neighbour cross-linking analysis was performed using a modi-
ﬁcation of methods described previously (24). Brieﬂy, dithio-
bis(succinimidylpropionate) (DSP) (Thermo Scientiﬁc) was
dissolved in DMSO at 100 mM and added to 100 ml of syn-
thetic enamel ﬂuid (43) containing recombinant WT or
Y64H amelogenin at 2 mg/ml to give a ﬁnal DSP concen-
tration of 5 mM. The mixture was incubated at room tempera-
ture for 10 min before quenching the reaction by the addition
of 20 ml of 500 mM Tris (pH 6.8). Samples were diluted 3:1
(vol/vol) with either reducing or non-reducing 4  concen-
trated SDS–PAGE loading buffer and the molecular size of
cross-linked amelogenins determined by loading 5 mlo n
12% SDS gels containing 6M urea run at a constant 200 V.
Resolved proteins were detected by Coomassie Blue staining.
In vitro degradation of recombinant WT and Y64H
amelogenins by secretory stage developing enamel
proteases
Secretory enamel protease extract (containing principally
MMP20 enzyme) was obtained from the developing enamel
of rat mandibular incisors. Male Wistar rats were sacriﬁced
by cervical dislocation and the lower incisors dissected free
of the jaws. The adhering enamel organs were wiped away
using damp paper tissue and the teeth allowed to air dry
until the white opaque zone was visible. A scalpel was used
to dissect the developing enamel lying apical to the white
opaque zone clear of the underlying dentine. Secretory stage
enamel from two contra-lateral teeth was then extracted in
100 mlo f5 0m M Tris (pH 7.4) containing 10 mM CaCl2 by
grinding with a ﬁne glass rod. The extracts were centrifuged
at 20 000g for 10 min and the supernatant containing extracted
MMP20 removed. WT and Y64H recombinant amelogenins
were prepared in 50 mM Tris (pH 8.0) at a concentration of
1 mg/ml and mixed in equal volumes with the MMP20
extract. A 10 ml aliquot of the mixture was removed
immediately, diluted with 10 ml of SDS–PAGE sample
loading buffer containing a cocktail of protease inhibitors
and stored at 2808C until required. The remaining sample
was incubated at 378C and further aliquots were removed
after 8 and 24 h. Samples were analysed by loading 10 ml
per lane on 15% SDS–PAGE mini gels and stained with
Coomassie Blue.
Determination of transcript size using RT–PCR
LowerincisorsdissectedfromWTandhemizygousmutantmale
mice mandibles (n ¼ 3) were immediately placed into
RNAlaterTM solution (Applied Biosystems) for RNA preser-
vation in accordance with the manufacturer’s instructions.
RNAwasextractedfromwholemiceteethusingtheRibopureTM
kit (Applied Biosystems) according to the manufacturer’s
instructions. RNA was evaluated using spectrophotometry and
gel electrophoresis and subjected to DNase treatment to
remove contaminating DNA using the Turbo DNA-freeTM kit
(Applied Biosystems). Reverse transcription was performed
using the Transcriptor First Strand cDNA synthesis kit
(Roche). The resulting cDNA was used in a PCR reaction
(Phire hot start DNA polymerase Finnzymes—New England
Biolabs) with primers designed to amplify a 536 bp product of
thegene(50-atgcccctaccacctcatc-30 and50-acttcttcccgcttggtctt-30)
along with other potential PCR products corresponding to alter-
natively spliced amelogenin mRNAs.
Site-directed mutagenesis and plasmid construction
TheY64HmutationwasintroducedintoaratamelogenincDNA
(44) using the ‘Quick Change’ site-directed mutagenesis kit
(Stratagene) and the primers 50-GCATGATAAGGCAGCCG
CATCCTTCCTATGGTTAC-30 and 50-GTAACCATAGGAA
GGATGCGGCTGCCTTATCATGC-30. This strategy yielded
a mutant amelogenin cDNA of identical amino acid sequence
to that of the mouse. Subsequently, cDNAs encoding WT and
mutant amelogenin were sub-cloned into the expression vector
pSG5-HA. A full-length ameloblastin cDNA (IMAGE clone




COS-7 cells were cultured on coverslips in DMEM containing
10% fetal bovine serum at 378C and 5% CO2. Once cells had
reached 90% conﬂuence, they were transfected with 8 mgo f
each construct using Lipofectamine 2000 according to the
manufacturer’s instructions (Invitrogen) and incubated as
above for 18 h. Transfections omitting the DNA constructs
were set up as negative controls. Subsequently, cells were
ﬁxed in ice cold 4% paraformaldehyde and autoﬂuorescence
was quenched by treating cells ﬁrst with 50 mM ammonium
chloride in PBS and then in 0.1 M glycine. The cells were
then made permeable using 0.1% Triton X-100 in PBS and
amelogenin and ameloblastin expression detected using the
appropriate ﬂuorescently labelled antibody (see above). Immu-
nolabelled cells were examined on a Delta Vision RT (Applied
Precision) restoration microscope using a 100x/1.4 Uplan Apo
objective and the Sedat ﬁlter set (Chroma 89000 v2). Images
were collected using a Coolsnap HQ (Photometrics) camera
with a Z optical spacing of 0.2 mm. Raw images were then
deconvoluted using the Softworx software and displayed as
maximum intensity projections.
In parallel experiments, COS-7 cells were transfected as
above and cell death was detected by TUNEL assay using
the ‘In situ cell death’ kit (Roche) according to the manufac-
turer’s instructions. Ten contiguous images of each sample
were collected using a  20 objective lens and the percentage
of TUNEL-positive cells in each sample determined. Results
were analysed by 1-way ANOVA followed by a Bonferroni
multiple comparison test using Graphpad Prism
w v5.0 soft-
ware (Graphpad, San Diego, CA, USA). Results were taken
to be statistically signiﬁcant at the P , 0.05 level.
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